About: http://data.cimple.eu/news-article/bf71ed40508ccef7bc07672b9eceaf54fc568d464f54b7f338c9e41b     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic. High hopes hang on the small vials of liquid on show at a Beijing trade fair this week -- vaccine candidates produced by Chinese companies Sinovac Biotech and Sinopharm. Neither has hit the market yet but the makers hope they will be approved after all-important phase 3 trials as early as year-end. A Sinovac representative told AFP his firm has already "completed the construction of a vaccine factory" able to produce 300 million doses a year. On Monday, people at the trade fair crowded around booths showing the potential game-changing vaccines. China, which is facing a storm of foreign criticism over its early handling of the pandemic, has been trying to repurpose the story of Covid-19. State media and officials are now emphasising the revival of Wuhan, the central Chinese city where the deadly pathogen surfaced, as a success story in the fight against the virus. They are also touting progress on domestic vaccines as a sign of Chinese leadership and resilience in the face of an unprecedented health threat that has pummelled the global economy. In May, President Xi Jinping pledged to make any potential vaccine developed by China a "global public good". The potential vaccines on display are among nearly 10 worldwide to enter phase 3 trials, typically the last step ahead of regulatory approval, as countries race to stub out the virus and reboot battered economies. Sinopharm said it anticipates the antibodies from its jab to last between one and three years -- although the final result will only be known after the trials. China's nationalistic tabloid Global Times reported last month that "the price of the vaccines will not be high". Every two doses should cost below 1,000 yuan ($146), the report said, citing Sinopharm's chairman, who told media he has already been injected with one of the candidate vaccines. China's official Xinhua news agency reported Monday that another vaccine candidate, developed by Chinese military scientists, can deal with mutations in the coronavirus. As of last month, at least 5.7 billion doses of the vaccines under development around the world had been pre-ordered. But the World Health Organization has warned that widespread immunisation against Covid-19 may not be on the cards until the middle of next year. bys/apj/axn
schema:headline
  • China shows off Covid-19 vaccines for first time
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software